在心力衰竭患者中以指导方针为导向的医疗疗法和结果,改善了喷射分数
Kyung H Min1, Alan S Go2, Keane Lee3
1Department of Medicine, Kaiser Permanente San Francisco Medical Center, San Francisco, California, USA.
Journal of the American College of Cardiology
|July 30, 2025
概括
心力衰竭的很大一部分患者降低了喷射率,改善了喷射率 (HFimpEF),但仍然面临临临床风险. 持续的指南导向医学治疗 (GDMT) 对于管理HFimpEF结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 临床医学 临床医学
- 流行病学 流行病学
背景情况:
- 心力衰竭改善喷射率 (HFimpEF) 患病率正在随着心力衰竭减少喷射率 (HFrEF) 的新疗法而上升.
- 有限的当代数据存在于HFimpEF流行病学,管理和结果.
- 这项研究解决了大型医疗保健系统中关于HFimpEF的知识差距.
研究的目的:
- 为了描述HFimpEF的流行病学.
- 分析指南导向医疗疗 (GDMT) 在HFimpEF中的使用.
- 为了评估HFimpEF患者的临床结果.
主要方法:
- 在一个大型综合卫生系统中,从2013年至2022年确定了减少喷射率 (HFrEF) 的心力衰竭病例.
- 定义HFimpEF为HFrEF,射出分数>40%和>10%的绝对改善在12个月内.
- 在HFimpEF和持续的HFrEF组之间比较恶化的心力衰竭事件和死亡率,分析GDMT使用.
主要成果:
- 在28292名HFrEF患者中,30.6%的患者在12个月内发展出HFimpEF.
- 使用指南导向医学疗法 (GDMT) 后的HFimpEF诊断略有下降.
- 与持续的HFrEF相比,HFimpEF患者心力衰竭恶化率显著降低 (17.4 vs 34.1/100人年) 和死亡率 (5.7 vs 11.0/100人年) 显著降低.
结论:
- 很大一部分HFrEF患者过渡到HFimpEF,但仍然存在相当大的临床风险.
- 停用GDMT与HFimpEF的临床风险增加有关.
- 需要进一步研究持续的GDMT遵守和优化HFimpEF结果.
相关概念视频
01:30Heart Failure V: Medical Management
25
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
25
01:22Heart Failure VI: Adjunct Therapies
28
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
28
01:30Heart Failure IV: Classification and Diagnostic Evaluation
33
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
33
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
510
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
510
01:30Heart Failure VII: Nursing Interventions
140
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
140
01:28Mitral Regurgitation IV: Nursing Management
84
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
84